Stuart W. Peltz
2021
In 2021, Stuart W. Peltz earned a total compensation of $11M as Chief Executive Officer at PTC Therapeutics, a 4% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $835,300 |
---|---|
Option Awards | $7,550,900 |
Salary | $768,750 |
Stock Awards | $1,835,124 |
Other | $32,249 |
Total | $11,022,323 |
Peltz received $7.6M in option awards, accounting for 69% of the total pay in 2021.
Peltz also received $835.3K in non-equity incentive plan, $768.8K in salary, $1.8M in stock awards and $32.2K in other compensation.
Rankings
In 2021, Stuart W. Peltz's compensation ranked 885th out of 12,415 executives tracked by ExecPay. In other words, Peltz earned more than 92.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 885 out of 12,415 | 93rd |
Division Manufacturing | 290 out of 5,508 | 95th |
Major group Chemicals And Allied Products | 97 out of 2,378 | 96th |
Industry group Drugs | 82 out of 2,099 | 96th |
Industry Pharmaceutical Preparations | 53 out of 1,549 | 97th |
Source: SEC filing on April 28, 2022.
Peltz's colleagues
We found four more compensation records of executives who worked with Stuart W. Peltz at PTC Therapeutics in 2021.